Connor Ojard, MD
Orthopaedic Surgery · Cullman, ALNPI 1376922823
Payments from drug & device makers
Across 67 payments — averaging $107.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Prime Surgical, LLC$2K
- ALON Medical Technology$2K
- AbbVie$255
- Smith+Nephew$207
- Pacira Pharmaceuticals Incorporated$193
- plus $757 from 17 others
What the payments were for
- Travel & lodging$1,27118%
- Food & beverage$1,81325%
- Education$4,09157%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 17 | $2,236 |
| Prime Surgical, LLC | 4 | $1,986 |
| ALON Medical Technology | 1 | $1,541 |
| AbbVie | 11 | $255 |
| Smith+Nephew | 4 | $207 |
| Pacira Pharmaceuticals Incorporated | 4 | $193 |
| Amgen | 2 | $135 |
| Stryker | 2 | $122 |
| Johnson & Johnson(2 entities) | 4 | $76 |
| ANI Pharmaceuticals, Inc. | 2 | $64 |
| Ossur Americas, Inc. | 1 | $57 |
| Urgo Medical North America, LLC | 2 | $37 |
| Bioventus LLC | 2 | $37 |
| Abbott | 2 | $34 |
| Solventum Corporation | 1 | $32 |
| Kerecis Limited | 1 | $31 |
| Illuminoss Medical, Inc. | 1 | $30 |
| Vertex | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| ERMI LLC | 1 | $17 |
| Medtronic | 1 | $14 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,175 in reported general payments places this provider in the 65th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 342 | $2,534 |
| Diclofenac Sodium | 43 | $1,001 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 66 | $552 |
| Ondansetron Hcl | 66 | $313 |
| Tramadol Hcl | 49 | $210 |
| Cyclobenzaprine Hcl | 29 | $180 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 33 | $178 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $161 |
| Methocarbamol | 12 | $83 |
| Meloxicam | 22 | $62 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Cullman
- Jeffrey DugasBirmingham$11.7M
- Benton EmblomBirmingham$3.1M
- James SmithGadsden$2.7M
- Herrick SiegelBirmingham$1.3M
- Paul CanaleDaphne$609K
- Kenneth MooreBirmingham$342K
- Jeffrey DavisBirmingham$293K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$219K
- Lawrence LemakVestavia$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.